Transfemoral aortic valve implantation in a patient with mitral bioprosthesis: technical features and forethoughts.
نویسندگان
چکیده
Transfemoral Aortic Valve Implantation in a Patient With Mitral Bioprosthesis: Technical Features and Forethoughts protruding 9 mm into the left ventricular outflow tract (LVOT), but with sufficient space in the LVOT (in theory) to accommodate the TAV (Fig. 1). During the aortic valvuloplasty procedure, displaceImplante de válvula aórtica transfemoral en paciente con prótesis biológica mitral: aspectos técnicos y precauciones
منابع مشابه
Transfemoral aortic valve implantation in severe aortic stenosis patients with prior mitral valve prosthesis
INTRODUCTION Transcatheter aortic valve implantation for severe symptomatic aortic stenosis in patients with a previous mitral valve prosthesis is technically challenging, and pre-procedural comprehensive assessment of these patients before transcatheter aortic valve implantation is vital for an uncomplicated and successful procedure. AIM We want to share our experience with transcatheter aor...
متن کاملValvular Heart Disease Thirty-Day Results of the SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) Registry A European Registry of Transcatheter Aortic Valve Implantation Using the Edwards SAPIEN Valve
Background—Transcatheter aortic valve implantation was developed to mitigate the mortality and morbidity associated with high-risk traditional aortic valve replacement. The Edwards SAPIEN valve was approved for transcatheter aortic valve implantation transfemoral delivery in the European Union in November 2007 and for transapical delivery in January 2008. Methods and Results—The SAPIEN Aortic B...
متن کاملAortic valve replacement and mitral valve repair as treatment of complications after percutaneous core valve implantation.
CLINICAL SUMMARY We describe the case of a 66-year-old man who had surgical intervention for a core valve malfunction 3 months after transfemoral implantation. The patient was scheduled for percutaneous aortic valve implantation (PAVI) because of the presence of numerous risk factors, such as obesity (body mass index, 35%) and myelodysplasia. The main concern about elective standard aortic valv...
متن کاملEmergency transapical mitral valve-in-valve implantation for bioprosthesis failure: transapical implantation of an Edwards Sapien-XT in a dysfunctional mitral bioprosthesis in a critical patient
Background: Valve-in-Valve (VIV) Transcatheter Aortic Valve Replacement (TAVR) is now the treatment of choice in high-surgical-risk patients with failing aortic bioprosthesis. Although less performed, VIV-Transcatheter Mitral Valve Replacement (TMVR) is a valid treatment option for selected high-risk patients with degenerated mitral bioprostheses. Several cases of elective ViVTAVR and -TMVR hav...
متن کاملSuccessful percutaneous implantation of Symetis ACURATE neo transcatheter aortic bioprosthesis in a patient with existing mechanical mitral valve
A 73-year old woman who had previous mechanical mitral valve replacement (MVR) presented with worsening symptoms of dyspnea. Echocardiographic evaluation revealed severe aortic stenosis with calcified trileaflet aortic valve (aortic valve area was 0.9 cm2, mean gradient was 42 mm Hg with 45% ejection fraction). Society of Thoracic Surgeons score of the patient was 8.9%, mean logistic European s...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Revista espanola de cardiologia
دوره 65 9 شماره
صفحات -
تاریخ انتشار 2012